Navigation Links
Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
Date:5/20/2008

ST. LOUIS, May 20 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) today reported on the favorable endorsements of its Niobe(R) Magnetic Navigation System and Odyssey(TM) information management tools received from key opinion leaders in electrophysiology at Heart Rhythm 2008, the Heart Rhythm Society's 29th Annual Scientific Sessions, which concluded on Saturday, May 17.

In his core curriculum presentation, Dr. Xu Chen of the Rigshospitalet -- Copenhagen University Hospital, reported 100% acute success and 92% chronic success, with zero complications, in pediatric supraventricular tachycardia cases performed with the Niobe System. In addition, the remote magnetic navigation system lowered his patients' mean x-ray exposure to only five minutes, which is even more important in the pediatric population to minimize the potential long-term effects of radiation on children. Dr. Chen remarked on the Niobe System's safety, pointing out how the flexible, magnetically-guided catheter significantly reduces the risk of perforation.

Prof. Tamas Szili-Torok of Erasmus Medical Center in Rotterdam reported in a core curriculum presentation that remote magnetic navigation is now the standard of care for pediatric cases at Erasmus, due to its greater safety and ability to navigate complex anatomy. He presented 100% acute success and 81% chronic success in pediatric supraventricular tachycardia cases with the Niobe System at one-year follow-up, and 92% and 75% acute and chronic success, respectively, in the even more challenging congenital heart disease cases, also at one-year follow-up. His patients experienced zero complications related to the Niobe system during these complex procedures.

In all, 90% of the 96 core curriculum sessions presented at Heart Rhythm 2008, including all 33 sessions related to ablation techniques, included presentations delivered by physicians from institutions that have already purchased or ordered a Niobe(R) Magnetic
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
2. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
3. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
4. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
5. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
8. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
9. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
10. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
11. Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Global Self Monitoring Bloo...ive Growth ,, http://www.reportlinker.com/p0...-(SMBG )-Increasing-Adoption-to-Drive-Growth.html#...mpaign=prnewswire ,, Description ,, Globa...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Global Markets for Assisted...ortlinker.com/p0164742/Global-Markets-for-Assisted...ire&utm_medium=pr&utm_campaign=prnewswire ...overs the U.S., 15 Countries in Europe and Japan. ...
(Date:11/20/2009).... 20 Cyberonics, Inc. (N...sident and Chief Executive Officer, and Greg Brown...st Annual Piper Jaffray Health Care Conference in ...M EST. The conference session and webcast will be.... Piper Jaffray will host a webcast of the presen...
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 1WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 2WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 3Leg Clots May Not Travel to Lungs 59796 1Leg Clots May Not Travel to Lungs 59796 2Leg Clots May Not Travel to Lungs 59796 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6
...-May 14, 2007 - Oculus Innovative,Sciences, Inc. (...nology was the subject of a poster presentation at...conference that was held in,Glasgow, Scotland this... About an Antimicrobial,Solution in the Treatment ... Harding infection criteria to evaluate the,perfor...
...ion and Symptom Severity; New,Resources for Patien...USNewswire/ -- A new survey,released today by the ...ma sufferers are not exactly breathing easy these ...ma medication categories,somewhat or not at all, a...geable adult patients tend to be about asthma. In ...
Other Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3New Survey Finds Troubling Data on American Asthma Sufferers 2New Survey Finds Troubling Data on American Asthma Sufferers 3New Survey Finds Troubling Data on American Asthma Sufferers 4New Survey Finds Troubling Data on American Asthma Sufferers 5New Survey Finds Troubling Data on American Asthma Sufferers 6
(Date:11/21/2009)..., WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -...liminate onchocerciasis (river blindness) in the A...f the disease in recent years, as evidenced by a 3... mass drug administration in six endemic countries...meeting of the American Society of Tropical Medici...
(Date:11/21/2009)... NH based medical credentialing s...its industry to form a partnerhsip with Amerinet, ...his partnership will help to transform quality car... (Vocus) November 21, 2009 -- ISG Group, L...nced a new agreement with Amerinet Inc., a leading...
(Date:11/21/2009)... Eric J. Hall, president and chie...of America (AFA) issued the following statement re...ction as part of the new annual wellness for Medic...and Affordable Care Act" that was introduced ...Y (PRWEB) November 21, 2009 -- Eric J. Hall, presi...
(Date:11/20/2009)..., Pioneering Neurologist Closer to Understanding ...0 Dr. Jeremy Schmahmann... and neurologist at the Massachusetts General Hosp...d his laboratory,s research on the new field of st...Dlink Foundation. ,, Dr. Schmahmann is an award...
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswire...ops urged the Senate to make essential changes its...ral law on abortion funding and conscience protect... immigrants and include strong provisions for adeq...enate health care bill an "enormous disappointment...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
...Patient Volumes Seen in Houston Physician-Owned Ho...rs-InterStudy , , NASHVILLE, Tenn., March 23 Hea...ed care market intelligence, reports that while Te... actually yield increasing challenges for this sec...
...ne, Ph.D. Honored for Distinguished Service in the... 23 NovaBay Pharmaceuticals, Inc. (NYSE Alternext...st M. Frederick Hawthorne, Ph.D., a member of the ...). Dr. Hawthorne, who is co-director of the Inter...
...n is One of Three FDA Approvals Spanning Lilly Neu...U.S. Food and Drug Administration (FDA) has approv... fluoxetine HCl capsules), Eli Lilly and Company (... "Living with major depressive disorder is difficu...
... March 23 According to the National Bureau of Eco...ce December 2007 and nearly half of U.S. residents... Winfrey replaced her annual ,Favorite Things, hol...cted to grow into a trillion dollar trade by 2010....
...e "2008 European Tissue Sealants & Topical Hem...s conferred on Nycomed in recognition of its revol...al patch, TachoSil is poised to be the future of t...d, with TachoSil, is the sole company in the marke...
... Gilbert joins The Association after serving a... for the American Red Cross in Washington, D.C. In...bert was responsible for eight service areas and 7...ore than $30 million in chapter grants. , ...
Other Medicine News:Health News:In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn 2Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 2Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 3Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 2Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 3Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 4Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 5Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 6Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 7Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 8Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 9Health News:FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression 10Health News:Consumers Redefine Value in the Recession: Sauna Sales Prove Preventive Health Is an Essential Investment 2Health News:Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation 2Health News:Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation 3Health News:Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation 4Health News:Jane H. Gilbert Appointed President and Chief Executive Officer of The ALS Association 2Health News:Jane H. Gilbert Appointed President and Chief Executive Officer of The ALS Association 3
...t Manager (IM) is an instrument and LIS independen...bles laboratories to work more efficiently than ev...hat stands between instrument or medical devices a... gaps in functionality between the two, as a conne...
L'Anthony 40
... detecting and grading acquired color deficiency. ...ion of saturation thresholds for bluish pigment co...nces between normal and acquired vision defects. C... discriminates between congenital and acquired dys...
... a rapid field or laboratory test for the differen...mple, two-step test provides results in 10 minutes...ient outcomes. , ,Intended use: The NOW® H...ostic test for the detection of Hepatitis B surfac...
Medicine Products: